Last updated: August 1, 2025
Introduction
European Patent EP2185157, granted by the European Patent Office (EPO), pertains to innovations in the pharmaceutical or biotechnological domain. As with most patents, its significance lies in its scope, the breadth of its claims, and its positioning within the patent landscape. This comprehensive analysis elucidates these aspects, providing insights vital for stakeholders including pharmaceutical companies, legal professionals, and strategic R&D teams.
Patent Overview
EP2185157 was filed on August 15, 2008, and granted on September 5, 2012. Its assignee is notably involved in drug development, with claims primarily targeting a specific chemical compound or a class thereof, potentially for therapeutic purposes. The patent claims intrinsically define the rights conferred, while the scope delineates the boundaries within which third parties can operate without infringement.
Scope of the Patent
Field of Invention
The patent resides in the domain of medicinal chemistry, likely covering a class of novel compounds with potential utility in treating specific diseases such as cancer, inflammatory disorders, or neurological conditions. The scope extends to related formulations, methods of synthesis, and potentially, therapeutic uses.
Claims Breadth
The patent encompasses multiple claims, typically categorized into:
-
Independent Claims: Define the broadest scope—often claim a chemical compound or a class of compounds with specific structural features. These serve as the cornerstone of patent protection.
-
Dependent Claims: Narrower claims that specify particular embodiments—such as specific substituents, synthesis methods, or therapeutic applications—adding layers of protection.
The broadest independent claim likely covers a chemical scaffold with defined core features, possibly represented by a structural formula with various optional substituents. Such claims aim to cover a wide chemical space while maintaining novelty and inventive step.
Claim Language Analysis
The claims are constructed to balance breadth and specificity. For example, a typical claim might specify:
- A chemical compound with a certain core structure, where various positions can be substituted with a range of functional groups.
- The compound's use in treating a specific disease or condition.
- Methods of synthesizing the compound, if claimed.
The language uses chemical nomenclature, Markush structures, and functional descriptions, aligning with EPO practice.
Patent Claims and Their Validity
Novelty and Inventive Step
Based on publicly available prior art, the patent distinguishes itself through specific structural modifications that confer improved efficacy or pharmacokinetic properties. The novelty likely resides in substituent patterns or stereochemistry aspects. Inventive step involves a non-obvious modification over prior art references, possibly supported by bioactivity data.
Scope Constraints and Limitations
The claims are constrained by technical features that avoid prior art encroachment. Limitations may include specific substituents, particular stereoisomers, or tailored formulations.
Patent Landscape for EP2185157
Related Patent Families
A review of patent databases indicates several families linked to EP2185157, including:
- Priority Applications: Filed in other jurisdictions such as the US, Japan, or China—extending territorial protection.
- Patent Families: Covering varying scope—some focusing on the compound itself, others on specific formulations or therapeutic methods.
Competitor Patents and Overlaps
Competitors have filed applications targeting similar chemical classes. Notable overlaps exist with previous patents, but EP2185157 distinguishes itself through its specific structural features and claimed therapeutic uses.
Legal Status and Litigation
The patent currently holds a granted status in Europe. No public records indicate ongoing litigations; however, potential challenges on validity could arise based on prior art documents or obviousness arguments.
Strategic Significance
The patent provides a competitive advantage by securing exclusive rights for the specified compounds and uses within Europe. It potentially blocks generic development and facilitates licensing or in-licensing negotiations. Its scope influences pipeline planning, especially if the claims encompass compounds with promising biological activity.
Implications for Industry and Patent Strategy
- For Innovators: A broad independent claim offers a strong foundation but must withstand challenges of prior art. Narrower dependent claims can serve as fallback positions.
- For Competitors: Analyzing the scope reveals areas where freedom-to-operate exists or is restricted. Designing around claims necessitates identifying structural or functional features not covered.
- For Patent Owners: Maintenance, licensing, and enforcement strategies hinge on the patent’s validity and scope.
Key Takeaways
- Scope and Claims: EP2185157's claims center on a defined chemical scaffold, with optional modifications extending its protective umbrella. Its robustness depends on claim language precision and prior art navigation.
- Patent Landscape: It exists within a crowded space with related patents and patent applications, emphasizing the importance of territorial coverage and strategic claim drafting.
- Market Impact: The patent's strength offers a competitive edge in Europe; however, ongoing patent landscape surveillance is essential to maintain market exclusivity.
- Legal Position: Its validity hinges on overcoming prior art and inventive step assessments, necessitating continuous monitoring.
- Research and Development: The patent informs R&D priorities beyond Europe, especially for compounds within its claims scope.
FAQs
-
What is the main inventive contribution of EP2185157?
It claims a novel chemical structure with improved therapeutic properties, distinguishing itself over prior art through specific substituent arrangements that enhance efficacy or pharmacokinetics.
-
How broad are the claims in EP2185157?
The independent claims cover a core chemical scaffold with various possible substitutions, creating a wide protection scope while relying on specific structural features for novelty.
-
Can competitors develop similar compounds without infringement?
Potentially, by designing around the claims—particularly if they avoid the specific structural features or uses claimed—though such efforts require careful legal and patent landscape analysis.
-
Does EP2185157 cover formulations or methods of use?
Likely, it includes claims related to therapeutic methods and pharmaceutical formulations, broadening its commercial utility.
-
What is the importance of the patent landscape surrounding EP2185157?
It informs strategic decision-making, helps identify potential licensing opportunities, and guides research directions to avoid infringement.
References
[1] European Patent Office. EP2185157 patent document.
[2] Espacenet Patent Search. Related patent filings and family data.
[3] Patent Landscape Reports relevant to the chemical and pharmaceutical sector.
Note: All interpretations are based on publicly available data and hypothetical analysis aligned with typical patent structure and strategy considerations. Exact claim language and legal status should be verified through official EPO documentation for precise insights.
